TY  - GEN
AU  - Coleman,Robert L
AU  - Oza,Amit M
AU  - Lorusso,Domenica
AU  - Aghajanian,Carol
AU  - Oaknin,Ana
AU  - Dean,Andrew
AU  - Colombo,Nicoletta
AU  - Weberpals,Johanne I
AU  - Clamp,Andrew
AU  - Scambia,Giovanni
AU  - Leary,Alexandra
AU  - Holloway,Robert W
AU  - Gancedo,Margarita Amenedo
AU  - Fong,Peter C
AU  - Goh,Jeffrey C
AU  - O'Malley,David M
AU  - Armstrong,Deborah K
AU  - Garcia-Donas,Jesus
AU  - Swisher,Elizabeth M
AU  - Floquet,Anne
AU  - Konecny,Gottfried E
AU  - McNeish,Iain A
AU  - Scott,Clare L
AU  - Cameron,Terri
AU  - Maloney,Lara
AU  - Isaacson,Jeff
AU  - Goble,Sandra
AU  - Grace,Caroline
AU  - Harding,Thomas C
AU  - Raponi,Mitch
AU  - Sun,James
AU  - Lin,Kevin K
AU  - Giordano,Heidi
AU  - Ledermann,Jonathan A
TI  - Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
SN  - 1474-547X
PY  - 2018///0928
KW  - Aged
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Indoles
KW  - administration & dosage
KW  - Internationality
KW  - Maintenance Chemotherapy
KW  - methods
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Ovarian Neoplasms
KW  - mortality
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Risk Assessment
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/S0140-6736(17)32440-6
ER  -